vs
Biglari Holdings Inc.（BH）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Biglari Holdings Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.4倍（$99.9M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -49.9%，领先434.0%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 9.6%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 5.7%）
Biglari控股是一家总部位于美国得克萨斯州圣安东尼奥的控股公司，由企业家萨达尔·比格拉里创立。旗下业务涵盖餐饮、出版、保险、石油能源多个领域，旗下子品牌包括Steak 'n Shake、《马克西姆》杂志、第一卫士保险、南先锋保险、南方石油、阿布拉克萨斯石油等。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BH vs RIGL — 直观对比
营收规模更大
BH
是对方的1.4倍
$69.8M
营收增速更快
RIGL
高出11.6%
9.6%
净利率更高
RIGL
高出434.0%
-49.9%
两年增速更快
RIGL
近两年复合增速
5.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $99.9M | $69.8M |
| 净利润 | $-49.9M | $268.1M |
| 毛利率 | 58.3% | 91.5% |
| 营业利润率 | -64.1% | 33.2% |
| 净利率 | -49.9% | 384.0% |
| 营收同比 | 9.6% | 21.2% |
| 净利润同比 | -385.3% | 1769.2% |
| 每股收益（稀释后） | — | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BHRIGL
| Q4 25 | $99.9M | $69.8M | ||
| Q3 25 | $99.7M | $69.5M | ||
| Q2 25 | $100.6M | $101.7M | ||
| Q1 25 | $95.0M | $53.3M | ||
| Q4 24 | $91.1M | $57.6M | ||
| Q3 24 | $90.4M | $55.3M | ||
| Q2 24 | $91.1M | $36.8M | ||
| Q1 24 | $89.5M | $29.5M |
净利润BHRIGL
| Q4 25 | $-49.9M | $268.1M | ||
| Q3 25 | $-5.3M | $27.9M | ||
| Q2 25 | $50.9M | $59.6M | ||
| Q1 25 | $-33.3M | $11.4M | ||
| Q4 24 | $-10.3M | $14.3M | ||
| Q3 24 | $32.1M | $12.4M | ||
| Q2 24 | $-48.2M | $-1.0M | ||
| Q1 24 | $22.6M | $-8.2M |
毛利率BHRIGL
| Q4 25 | 58.3% | 91.5% | ||
| Q3 25 | 58.1% | 93.2% | ||
| Q2 25 | 60.2% | 95.6% | ||
| Q1 25 | 60.3% | 91.7% | ||
| Q4 24 | 60.6% | 89.9% | ||
| Q3 24 | 59.9% | 85.5% | ||
| Q2 24 | 59.5% | 92.4% | ||
| Q1 24 | 61.5% | 93.1% |
营业利润率BHRIGL
| Q4 25 | -64.1% | 33.2% | ||
| Q3 25 | -7.6% | 40.9% | ||
| Q2 25 | 64.7% | 60.1% | ||
| Q1 25 | -43.3% | 23.9% | ||
| Q4 24 | -19.7% | 28.9% | ||
| Q3 24 | 47.9% | 25.4% | ||
| Q2 24 | -69.0% | 1.2% | ||
| Q1 24 | 32.9% | -23.6% |
净利率BHRIGL
| Q4 25 | -49.9% | 384.0% | ||
| Q3 25 | -5.3% | 40.2% | ||
| Q2 25 | 50.6% | 58.6% | ||
| Q1 25 | -35.0% | 21.5% | ||
| Q4 24 | -11.3% | 24.9% | ||
| Q3 24 | 35.5% | 22.5% | ||
| Q2 24 | -52.9% | -2.8% | ||
| Q1 24 | 25.2% | -27.9% |
每股收益（稀释后）BHRIGL
| Q4 25 | — | $14.11 | ||
| Q3 25 | — | $1.46 | ||
| Q2 25 | — | $3.28 | ||
| Q1 25 | — | $0.63 | ||
| Q4 24 | — | $0.82 | ||
| Q3 24 | — | $0.70 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $268.8M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $523.4M | $391.5M |
| 总资产 | $1.0B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BHRIGL
| Q4 25 | $268.8M | $155.0M | ||
| Q3 25 | $272.5M | $137.1M | ||
| Q2 25 | $32.8M | $108.4M | ||
| Q1 25 | $28.7M | $77.1M | ||
| Q4 24 | $30.7M | $77.3M | ||
| Q3 24 | $29.9M | $61.1M | ||
| Q2 24 | $26.9M | $49.1M | ||
| Q1 24 | $34.5M | $49.5M |
总债务BHRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益BHRIGL
| Q4 25 | $523.4M | $391.5M | ||
| Q3 25 | $580.3M | $117.6M | ||
| Q2 25 | $589.3M | $81.9M | ||
| Q1 25 | $539.8M | $18.6M | ||
| Q4 24 | $573.0M | $3.3M | ||
| Q3 24 | $601.8M | $-14.6M | ||
| Q2 24 | $569.2M | $-29.9M | ||
| Q1 24 | $618.6M | $-31.7M |
总资产BHRIGL
| Q4 25 | $1.0B | $513.6M | ||
| Q3 25 | $1.1B | $242.5M | ||
| Q2 25 | $863.6M | $206.7M | ||
| Q1 25 | $829.1M | $176.0M | ||
| Q4 24 | $866.1M | $164.0M | ||
| Q3 24 | $865.1M | $139.4M | ||
| Q2 24 | $809.1M | $128.4M | ||
| Q1 24 | $885.3M | $126.5M |
负债/权益比BHRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.8M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $6.4M | — |
| 自由现金流率自由现金流/营收 | 6.4% | — |
| 资本支出强度资本支出/营收 | 11.4% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $76.6M | — |
8季度趋势，按日历期对齐
经营现金流BHRIGL
| Q4 25 | $17.8M | $22.0M | ||
| Q3 25 | $31.2M | $24.0M | ||
| Q2 25 | $42.1M | $30.5M | ||
| Q1 25 | $15.8M | $-893.0K | ||
| Q4 24 | $18.0M | $14.5M | ||
| Q3 24 | $10.8M | $21.7M | ||
| Q2 24 | $1.8M | $302.0K | ||
| Q1 24 | $19.1M | $-5.0M |
自由现金流BHRIGL
| Q4 25 | $6.4M | — | ||
| Q3 25 | $22.3M | — | ||
| Q2 25 | $39.4M | — | ||
| Q1 25 | $8.5M | — | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $3.7M | — | ||
| Q2 24 | $-10.0M | — | ||
| Q1 24 | $14.5M | — |
自由现金流率BHRIGL
| Q4 25 | 6.4% | — | ||
| Q3 25 | 22.4% | — | ||
| Q2 25 | 39.2% | — | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 12.0% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | -11.0% | — | ||
| Q1 24 | 16.2% | — |
资本支出强度BHRIGL
| Q4 25 | 11.4% | — | ||
| Q3 25 | 9.0% | — | ||
| Q2 25 | 2.7% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 7.8% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 13.0% | — | ||
| Q1 24 | 5.1% | — |
现金转化率BHRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | 0.83× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 0.33× | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BH
| Products | $45.9M | 46% |
| Franchisor | $20.5M | 21% |
| Insurance Operations | $19.1M | 19% |
| Oil And Gas Segment | $5.4M | 5% |
| Royalty | $4.1M | 4% |
| Abraxas Petroleum | $2.7M | 3% |
| Other | $2.2M | 2% |
RIGL
暂无分部数据
